Q&A: Poolbeg Pharma CEO Jeremy Skillington on its groundbreaking AI collaboration
Episode 1507, Jun 29, 2023, 11:48 AM
(Watch the video interview HERE)
Jeremy Skillington, CEO of Poolbeg Pharma (POLB ), talks us through the results of its successful collaboration with leading AI specialist CytoReason, making at a pioneer in AI-enabled drug discovery.
0:28 Discussing the results of the successful collaboration with AI-specialist CytoReason to study human challenge data for influenza, including validation of Poolbeg’s POLB001 treatment.
2:07 How the approach to analyse human challenge data for influenza with AI is the first of its kind.
3:28 Next steps after the successful conclusion of the collaboration, moving towards partnership.
4:54 Why Poolbeg is at the forefront of AI-enabled drug discovery
Jeremy Skillington, CEO of Poolbeg Pharma (POLB ), talks us through the results of its successful collaboration with leading AI specialist CytoReason, making at a pioneer in AI-enabled drug discovery.
0:28 Discussing the results of the successful collaboration with AI-specialist CytoReason to study human challenge data for influenza, including validation of Poolbeg’s POLB001 treatment.
2:07 How the approach to analyse human challenge data for influenza with AI is the first of its kind.
3:28 Next steps after the successful conclusion of the collaboration, moving towards partnership.
4:54 Why Poolbeg is at the forefront of AI-enabled drug discovery